Diabetic Foot Ulcer
Diabetic Foot Ulcer Market

Diabetic Foot Ulcer

Diabetic foot ulcer (DFU) is an open sore or wound in patients with diabetes; they occur in type 1 and type 2 diabetes mellitus. The average duration of diabetes before ulceration is >10 years. The wound is commonly located on the bottom of the foot. A DFU is caused by neuropathic (nerve) and vascular (blood vessel) complications of diabetes. Nerve damage due to diabetes causes altered or complete loss of feeling in the foot and/or leg, known as peripheral neuropathy.

Diabetic Foot Ulcer Epidemiological Segmentation

The Epidemiological Segmentation of DFU from 2019 to 2032 is segmented as:-

  • Total Prevalent Cases of Diabetic Foot Ulcer
  • Total Diagnosed Cases of Diabetic Foot Ulcer
  • Gender-specific Cases of Diabetic Foot Ulcer
  • Age-Specific Cases of Diabetic Foot Ulcer
  • Diabetic Foot Ulcer cases by severity/ chronicity of wound
  • Treated cases of Diabetic Foot Ulcer

Diabetic Foot Ulcer Epidemiology (2021) 

  • The total number of Diabetic Foot Ulcer prevalent cases in the 7MM is 6.1 Million
  • Diabetic Foot Ulcer diagnosed prevalence cases in males were observed to be 1.6 Million cases and in females, it was observed to be 1.1 Million cases.


Diabetic Foot Ulcer Market Drivers

  • Rich emerging pipeline
  • Development of new treatment modalities
  • Patients-friendly dosage regimes

Diabetic Foot Ulcer Market Barriers

  • The burden of high cost in DFU treatment
  • Post-operative challenges in DFU patients
  • Lack of access to specialists 

Diabetic Foot Ulcer Emerging Drugs

The emerging drugs of the DFU market are

  • TTAX01 (Neox Cord 1K)
  • Engensis (VM202; Donaperminogene Seltoplasmid)
  • ON101 (WH-1)
  • Allo-APZ2-DFU (ABCB5 positive MSCs)
  • Bisphosphocin Nu-3
  • AUP1602-C
  • RAPID Biodynamic PRP Haematogel
  • MBN-101 (Pravibismane)
  • ExpressGraft (C9T1 Skin Tissue), And many more

Diabetic Foot Ulcer Key Players

  • The key players in the DFU market are
  • Amniox (TissueTech)
  • Helixmith
  • Oneness Biotech
  • Rheacell (a subsidiary of Ticeba)
  • Lakewood-Amedex
  • Aurealis Therapeutics
  • Biotherapy Services
  • Microbion Corporation
  • Mallinckrodt, And many more